Skip to main content
Top
Published in: Endocrine 1/2024

27-11-2023 | Neuroendocrine Tumor | Brief report

Lost in translation: evaluating the readability of online patient information for neuroendocrine tumors

Authors: Alexander Paschke, Udhayvir Singh Grewal

Published in: Endocrine | Issue 1/2024

Login to get access

Abstract

Introduction

Recent data show that many patients with NETs do not receive sufficient education regarding their diagnosis and therefore tend to search for information or literature independently. We sought to assess the readability of OPI for neuroendocrine tumors and to analyze compliance to NIH guidelines for OPI (readability level 8th grade or below).

Methods

We performed a Google search to compile a list of the top ten OPI websites using the search term “neuroendocrine tumor”. We calculated median readability scores for each website across the 9 scales as well as overall readability scores across all sites.

Results

A total of 10 websites were included for analysis. 6/10 (60%) of the websites belonged to academic institutions, while 2/10 (20%) were from non-profit organizations, and 1 each were a government website (10%) and patient advocacy organization (10%). The median (with interquartile range or IQR) readability score for all websites across the nine readability tests was 9.6 (IQR 8.8–11.2).

Conclusion

Our findings underscore the need to develop online patient education material that is readable and therefore easily understandable for patients and caregivers dealing with this unique group of malignancies.
Literature
1.
go back to reference S. Leyden, T. Kolarova, C. Bouvier et al. Unmet needs in the international neuroendocrine tumor (NET) community: assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals. Int J. Cancer 146(5), 1316–1323 (2020)CrossRefPubMed S. Leyden, T. Kolarova, C. Bouvier et al. Unmet needs in the international neuroendocrine tumor (NET) community: assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals. Int J. Cancer 146(5), 1316–1323 (2020)CrossRefPubMed
2.
go back to reference T. Haugland, M.H. Vatn, M. Veenstra, A.K. Wahl, G.K. Natvig, Health related quality of life in patients with neuroendocrine tumors compared with the general Norwegian population. Qual. Life Res. 18(6), 719–726 (2009)CrossRefPubMed T. Haugland, M.H. Vatn, M. Veenstra, A.K. Wahl, G.K. Natvig, Health related quality of life in patients with neuroendocrine tumors compared with the general Norwegian population. Qual. Life Res. 18(6), 719–726 (2009)CrossRefPubMed
3.
go back to reference O. Husson, F. Mols, L.V. van de Poll-Franse, The relation between information provision and health-related quality of life, anxiety and depression among cancer survivors: a systematic review. Ann. Oncol. 22(4), 761–772 (2011)CrossRefPubMed O. Husson, F. Mols, L.V. van de Poll-Franse, The relation between information provision and health-related quality of life, anxiety and depression among cancer survivors: a systematic review. Ann. Oncol. 22(4), 761–772 (2011)CrossRefPubMed
Metadata
Title
Lost in translation: evaluating the readability of online patient information for neuroendocrine tumors
Authors
Alexander Paschke
Udhayvir Singh Grewal
Publication date
27-11-2023
Publisher
Springer US
Published in
Endocrine / Issue 1/2024
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-023-03607-0

Other articles of this Issue 1/2024

Endocrine 1/2024 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.